This page is the continuation of reference in support of Section 5b.
REFERENCES
Allred, D.C. Biological features of human premalignant breast disease and the progression to cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the Breast. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2009.
American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 7th edition, Edge, S.B., Byrd, D.R., Compton, C.C., et al (Eds), Springer, New York 2010.
Bloom, H.J., Richardson, W.W. (1957). Histological grading and prognosis in breast cancer. A study of 1,409 cases of which 359 have been followed for 15 years. Br J Cancer 11(3), 359-377. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2073885/
Chuba, P.J., Hamre, M.R., Yap, J., Severson, R.K., Lucas, D., Shamsa, F., Aref, A. (2005). Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol. 23(24):5534. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/16110014
De Leeuw, W.J., Berx, G., Vos, C.B., Peterse, J.L., Van de Vijver, M.J., Litvinov, S., Van Roy, F., Cornelisse, C.J., Cleton-Jansen, A.M. (1997). Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 183(4), 404. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pubmed/9496256
Elston, C.W., Ellis, I.O. (1991). Pathologic prognostic factors in breast cancer. I. The value of histological grades in breast cancer. Experience from a large study with long-term follow-up. Histopathology 19(5), 403–10. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pubmed/1757079
Fisher, E.R., Land, S.R., Fisher, B., Mamounas, E., Gilarski, L., Wolmark, N. (2004). Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer. 2004;100(2):238. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pubmed/14716756
King, T.A., Muhsen, S., Patil, S., Koslow, S., Oskar, S., Park, A., Morrogh, M., Sakr, R.A., Morrow, M. (2013). Is there a role for routine screening MRI in women with LCIS? Breast Cancer Res Treat. 142(2), 445-53. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871867/
Lakhani, S., Ellis, I., Schnitt, S., et al. (2012). WHO Classification of Tumours of the Breast, 4th ed. Lyon, IARC Press. (Retrieved November 6th 2014): http://apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&codcol=70&codcch=4004
Li, C.I., Uribe, D.J., Daling, J.R. (2005). Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93(9),1046. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361680/
National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. (Retrieved November 6th 2014): http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
Orvieto, E., Maiorano, E., Bottiglieri, L., Maisonneuve, P., Rotmensz, N., Galimberti, V., Luini, A., Brenelli, F., Gatti, G., Viale, G. (2008). Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution. Cancer. 2008;113(7):1511. (Retrieved November 14th 2014): http://onlinelibrary.wiley.com/doi/10.1002/cncr.23811/abstract;jsessionid=D749E671C9146F88E0664E47E09F40EB.f04t04
Page, D.L., Schuyler, P.A., Dupont, W.D., Jensen, R.A., Plummer,W.D. Jr, Simpson, J.F. (2003). Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361(9352), 125. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed/12531579
Rakha, E.A., El-Sayed, M.E., Lee, A.H., Elston, C.W., Grainge, M.J., Hodi, Z., Blamey, R.W., Ellis, I.O. (2008). Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J Clin Oncol. 26(19), 3153-8. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pubmed/18490649
Rakha, E.A., Ellis, I.O. (2010). Lobular breast carcinoma and its variants. Semin Diagn Pathol 27(1), 49-61. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pubmed/20306830
Schwartz, T., Cyr, A., Margenthaler, J. (2014). Screening breast magnetic resonance imaging in women with atypia or lobular carcinoma in situ. J Surg Res S0022-4804. (Retrieved November 6 2014): https://www.ncbi.nlm.nih.gov/pubmed/25277350
Simpson, J.L., Page, D.L. (1996). The role of pathology in premalignancy and as a guide for treatment and prognosis in breast cancer. Semin Oncol. 23(4), 428-35. (Retrieved November 6th 2014): https://www.ncbi.nlm.nih.gov/pubmed/8757269
Sinn, H-P., Kreipe, H. (2013). A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition. Breast Care (Basel) 8(2), 149–154. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683948/
Sullivan, T., Raad, R.A., Goldberg, S., Assaad, S.I., Gadd, M., Smith, B.L., Powell, S.N., Taghian, A.G. (2005). Tubular carcinoma of the breast: a retrospective analysis and review of the literature. Breast Cancer Res Treat 93(3),199. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed/16142444
Surveillance Epidemiology and End Results, National Cancer Institute (2005b). Characteristics of the SEER population compared with the total United States population. (Retrieved November 13th 2014): https://seer.cancer.gov/registries/characteristics.html
Thurman, S.A., Schnitt, S.J., Connolly, J.L., Gelman, R., Silver, B., Harris, J.R., Recht, A. (2004). Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. Int J Radiat Oncol Biol Phys 59(1), 152. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed/15093911
